Medicaid Bulletin

Effective Aug. 18, 2021, the Medicaid and NC Health Choice programs cover anifrolumab-fnia injection

Tobacco-related policy requirements go into effect on July 1, 2022.

Two Months Left to Submit Program Year 2021 Attestations; Security Risk Analysis

Providers are encouraged to confirm which PA types are included in this long-term design.

Will cover all U.S. FDA approved CAR T-Cell Therapies when administered per U.S. FDA approved guidelines

Temporary Suspension of Prior Authorization for Post-Acute Placements and Temporary Availability of the Hospital at Home Program

Casirivimab and Imdevimab have been given emergency use authorization for treatment of mild to moderate COVID-19 in some patients.

OSA has begun the Single Audit for state fiscal year 2021

Tips for providers to reduce the likelihood of future documentation errors

Billing codes for Medicaid beneficiaries